Overview

Daptomycin Versus Placebo in Patients With Neutropenia and Fever

Status:
Terminated
Trial end date:
2013-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the benefits and side effects of daptomycin compared to placebo for the treatment of neutropenic fever.
Phase:
Phase 3
Details
Lead Sponsor:
University of Rochester
Collaborator:
Cubist Pharmaceuticals LLC
Treatments:
Daptomycin